SET UP TAKHZYRO DOSING REMINDERS
As you know, TAKHZYRO is taken less often than some medicines. Signing up for texts or calendar alerts (or both!) can be an easy way to help stay on track with your dosing schedule.
TAKHZYRO Text Reminder Program
Want dosing reminders delivered straight to your mobile phone? Sign up for the TAKHZYRO Text Reminder Program! You'll receive 2 short texts to let you know it's time for you to take TAKHZYRO—one on the day before your dose and one on the day of your dose.
To get started, enter your mobile number here:
Please check your phone to complete your registration.
Message and data rates may apply. Average of 3 messages per month. Text HELP to 36395 for more information, or text STOP to 36395 to end text reminders. View Terms and Conditions. For any questions about TAKHZYRO, talk to your healthcare provider.
TAKHZYRO Time calendar alerts
Keep up with your dosing schedule by setting up TAKHZYRO Time calendar alerts to let you know when it's time for your next dose. Just follow the steps below.
For Google Calendar: a new calendar event based on your dosing schedule will pop up. All you have to do is save it.
For Apple Calendar and Outlook: double-click on the calendar file that appears to open the event and save it to your calendar. That's it!
Remember to always take TAKHZYRO exactly as prescribed. Even if you’re having fewer attacks, stick to your schedule. You’ve come a long way—don’t stop now!
WHAT IS TAKHZYRO?
TAKHZYRO is a prescription medicine used to prevent attacks of hereditary angioedema (HAE) in people 12 years of age and older.
It is not known if TAKHZYRO is safe and effective in children under 12 years of age.
IMPORTANT SAFETY INFORMATION
TAKHZYRO may cause serious side effects, including allergic reactions. Call your healthcare provider or get emergency help right away if you have any of the following symptoms:
- difficulty breathing
- chest tightness
- fast heartbeat
The most common side effects seen with TAKHZYRO were injection site reactions (pain, redness, and bruising), upper respiratory infection, and headache.
These are not all the possible side effects of TAKHZYRO. For more information, ask your healthcare provider or pharmacist. You may report side effects to the FDA at 1–800–FDA–1088.
TAKHZYRO has not been studied in pregnant or breastfeeding women. Talk to your healthcare provider about the risk of taking TAKHZYRO if you are pregnant, plan to be pregnant, are breastfeeding, or plan to breastfeed.
Please see full Prescribing Information, including information for patients.